Beam Therapeutics BEAM Cash Flow Statement (2019-2026)

NASDAQ BEAM
$25.15 -1.87 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Beam Therapeutics Quarterly Cash Flow Statement

Periods 31 quarters
Latest Sep 2026

Beam Therapeutics reported cash from operations of -$110.75M and free cash flow of -$111.96M for the quarter ended Sep 2026. This cash flow statement covers 31 quarters of results from Mar 2019 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-64.71M-69.21M-71.95M-109.58M-38.35M-96.46M-82.78M-96.09M142.80M-98.67M-91.05M-96.67M-90.35M-108.33M-102.14M-113.82M244.30M-94.32M-122.68M-134.41M
Depreciation and DepletionDep. & Depletion
2.56M3.26M3.42M3.47M3.94M4.65M4.82M5.19M5.36M5.43M5.58M5.48M5.44M5.53M5.54M5.56M5.67M5.61M5.41M5.45M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.04M0.06M0.11M
Depreciation & Amortization (CF)Dep. & Amort.
2.63M3.31M3.42M3.47M3.94M4.65M4.82M5.19M5.36M5.43M5.58M5.48M5.44M5.53M5.54M5.56M5.67M5.61M5.41M5.45M
Share-based CompensationStock Comp.
15.50M18.04M21.58M22.21M22.50M23.92M26.28M25.84M22.62M29.28M31.60M29.56M30.22M26.68M24.37M22.75M20.45M19.04M19.28M18.56M
Gains from Equity InvestmentsGains Equity
-25.50M
Gains from Investment SecuritiesGains Investment
4.70M
Gains from Sales and DivestituresGains Divest
0.00M
Other non-cash itemsOther Non-Cash
2.86M
Change in Working Capital
Change in ReceivablesChange Receivables
-300.00M
Change in Account PayablesChange Payables
2.47M
Change in Accrued ExpensesChange Accrued Exp.
-0.39M
Change in Other Operating AssetsOther Assets Change
-4.66M
Change in Other Operating LiabilitiesOther Liabilities Change
-3.52M
Other Working Capital ChangesOther WC Changes
1.14M
Cash from OperationsCash from Ops.
-110.75M
Investing Activities
Capital ExpendituresCapex
1.21M
Change in Property, Plant and EquipmentChange in PP&E
-1.21M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
109.63M
Sale and Maturity of InvestmentsInvestments Sold
212.70M
Cash from Investing ActivitiesCash from Investing
101.86M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
93.89M
Long-Term Debt RepaymentsLT Debt Repayment
0.54M0.55M0.57M0.58M0.59M0.60M0.62M0.40M0.63M0.18M0.11M0.20M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.54M-0.55M-0.57M-0.58M-0.59M-0.60M-0.62M-0.40M-0.63M-0.18M-0.11M-0.20M93.89M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.54M-0.55M-0.57M-0.58M-0.59M-0.60M-0.62M-0.40M-0.63M-0.18M-0.11M-0.20M93.89M
Change in Capital Stock
Common Stock IssuedStock Issued
2.33M
Net Shares Issued and RepurchasedNet Shares Issued
2.33M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
2.33M
Other financing activities (as filed)
-0.13M-0.01M-0.10M-0.03M-0.05M-0.06M-0.19M-0.38M-0.81M
Cash from Financing ActivitiesCash from Financing
2.33M
Additional items
Change in Cash
-6.56M
Free Cash FlowFCF
-111.96M
Net Cash FlowNCF
-6.56M
Interest Paid
2.59M
Income Taxes PaidTaxes Paid

Beam Therapeutics Cash Flow Statement API

Pull Beam Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BEAM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY